219 related articles for article (PubMed ID: 18669882)
1. Acid sphingomyelinase promotes lipoprotein retention within early atheromata and accelerates lesion progression.
Devlin CM; Leventhal AR; Kuriakose G; Schuchman EH; Williams KJ; Tabas I
Arterioscler Thromb Vasc Biol; 2008 Oct; 28(10):1723-30. PubMed ID: 18669882
[TBL] [Abstract][Full Text] [Related]
2. Sphingomyelinase converts lipoproteins from apolipoprotein E knockout mice into potent inducers of macrophage foam cell formation.
Marathe S; Choi Y; Leventhal AR; Tabas I
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2607-13. PubMed ID: 11116060
[TBL] [Abstract][Full Text] [Related]
3. Adeno-associated virus-mediated expression of acid sphingomyelinase decreases atherosclerotic lesion formation in apolipoprotein E(-/-) mice.
Leger AJ; Mosquea LM; Li L; Chuang W; Pacheco J; Taylor K; Luo Z; Piepenhagen P; Ziegler R; Moreland R; Urabe A; Jiang C; Cheng SH; Yew NS
J Gene Med; 2011 Jun; 13(6):324-32. PubMed ID: 21674735
[TBL] [Abstract][Full Text] [Related]
4. Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development.
Schissel SL; Jiang X; Tweedie-Hardman J; Jeong T; Camejo EH; Najib J; Rapp JH; Williams KJ; Tabas I
J Biol Chem; 1998 Jan; 273(5):2738-46. PubMed ID: 9446580
[TBL] [Abstract][Full Text] [Related]
5. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.
Jeong Ts; Schissel SL; Tabas I; Pownall HJ; Tall AR; Jiang X
J Clin Invest; 1998 Feb; 101(4):905-12. PubMed ID: 9466986
[TBL] [Abstract][Full Text] [Related]
6. Sphingomyelinase, an enzyme implicated in atherogenesis, is present in atherosclerotic lesions and binds to specific components of the subendothelial extracellular matrix.
Marathe S; Kuriakose G; Williams KJ; Tabas I
Arterioscler Thromb Vasc Biol; 1999 Nov; 19(11):2648-58. PubMed ID: 10559007
[TBL] [Abstract][Full Text] [Related]
7. The capacity of group V sPLA2 to increase atherogenicity of ApoE-/- and LDLR-/- mouse LDL in vitro predicts its atherogenic role in vivo.
Boyanovsky B; Zack M; Forrest K; Webb NR
Arterioscler Thromb Vasc Biol; 2009 Apr; 29(4):532-8. PubMed ID: 19164803
[TBL] [Abstract][Full Text] [Related]
8. Characterization of secretory sphingomyelinase activity, lipoprotein sphingolipid content and LDL aggregation in ldlr-/- mice fed on a high-fat diet.
Deevska GM; Sunkara M; Morris AJ; Nikolova-Karakashian MN
Biosci Rep; 2012 Oct; 32(5):479-90. PubMed ID: 22712892
[TBL] [Abstract][Full Text] [Related]
9. Rabbit aorta and human atherosclerotic lesions hydrolyze the sphingomyelin of retained low-density lipoprotein. Proposed role for arterial-wall sphingomyelinase in subendothelial retention and aggregation of atherogenic lipoproteins.
Schissel SL; Tweedie-Hardman J; Rapp JH; Graham G; Williams KJ; Tabas I
J Clin Invest; 1996 Sep; 98(6):1455-64. PubMed ID: 8823312
[TBL] [Abstract][Full Text] [Related]
10. Acid sphingomyelinase-deficient macrophages have defective cholesterol trafficking and efflux.
Leventhal AR; Chen W; Tall AR; Tabas I
J Biol Chem; 2001 Nov; 276(48):44976-83. PubMed ID: 11579092
[TBL] [Abstract][Full Text] [Related]
11. Sphingomyelinase induces aggregation and fusion of small very low-density lipoprotein and intermediate-density lipoprotein particles and increases their retention to human arterial proteoglycans.
Oörni K; Posio P; Ala-Korpela M; Jauhiainen M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1678-83. PubMed ID: 15879301
[TBL] [Abstract][Full Text] [Related]
12. Serum amyloid A and lipoprotein retention in murine models of atherosclerosis.
O'Brien KD; McDonald TO; Kunjathoor V; Eng K; Knopp EA; Lewis K; Lopez R; Kirk EA; Chait A; Wight TN; deBeer FC; LeBoeuf RC
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):785-90. PubMed ID: 15692094
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. A possible mechanism for low density lipoprotein and lipoprotein(a) retention and macrophage foam cell formation.
Tabas I; Li Y; Brocia RW; Xu SW; Swenson TL; Williams KJ
J Biol Chem; 1993 Sep; 268(27):20419-32. PubMed ID: 8376399
[TBL] [Abstract][Full Text] [Related]
14. Lipoprotein size and atherosclerosis susceptibility in Apoe(-/-) and Ldlr(-/-) mice.
Véniant MM; Withycombe S; Young SG
Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1567-70. PubMed ID: 11597927
[TBL] [Abstract][Full Text] [Related]
15. Low-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependent.
Yancey PG; Ding Y; Fan D; Blakemore JL; Zhang Y; Ding L; Zhang J; Linton MF; Fazio S
Circulation; 2011 Jul; 124(4):454-64. PubMed ID: 21730304
[TBL] [Abstract][Full Text] [Related]
16. Macrophage low-density lipoprotein receptor-related protein deficiency enhances atherosclerosis in ApoE/LDLR double knockout mice.
Hu L; Boesten LS; May P; Herz J; Bovenschen N; Huisman MV; Berbée JF; Havekes LM; van Vlijmen BJ; Tamsma JT
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2710-5. PubMed ID: 17038633
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of low density lipoprotein receptor eliminates apolipoprotein B100-containing lipoproteins from circulation and markedly prevents early atherogenesis in apolipoprotein E-deficient mice.
Murayama T; Yokode M; Horiuchi H; Yoshida H; Sano H; Kita T
Atherosclerosis; 2000 Dec; 153(2):295-302. PubMed ID: 11164418
[TBL] [Abstract][Full Text] [Related]
18. Rosuvastatin Reduces Aortic Sinus and Coronary Artery Atherosclerosis in SR-B1 (Scavenger Receptor Class B Type 1)/ApoE (Apolipoprotein E) Double Knockout Mice Independently of Plasma Cholesterol Lowering.
Yu P; Xiong T; Tenedero CB; Lebeau P; Ni R; MacDonald ME; Gross PL; Austin RC; Trigatti BL
Arterioscler Thromb Vasc Biol; 2018 Jan; 38(1):26-39. PubMed ID: 29162602
[TBL] [Abstract][Full Text] [Related]
19. Reduced apoptosis and plaque necrosis in advanced atherosclerotic lesions of Apoe-/- and Ldlr-/- mice lacking CHOP.
Thorp E; Li G; Seimon TA; Kuriakose G; Ron D; Tabas I
Cell Metab; 2009 May; 9(5):474-81. PubMed ID: 19416717
[TBL] [Abstract][Full Text] [Related]
20. NG2 Proteoglycan Ablation Reduces Foam Cell Formation and Atherogenesis via Decreased Low-Density Lipoprotein Retention by Synthetic Smooth Muscle Cells.
She ZG; Chang Y; Pang HB; Han W; Chen HZ; Smith JW; Stallcup WB
Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):49-59. PubMed ID: 26543095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
